These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26483897)

  • 21. Hypocretinergic interactions with the serotonergic system regulate REM sleep and cataplexy.
    Seifinejad A; Li S; Possovre ML; Vassalli A; Tafti M
    Nat Commun; 2020 Nov; 11(1):6034. PubMed ID: 33247179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypocretin in median raphe nucleus modulates footshock stimuli-induced REM sleep alteration.
    Hsiao YT; Lo Y; Yi PL; Chang FC
    Sci Rep; 2019 Jun; 9(1):8198. PubMed ID: 31160650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
    Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.
    Bourgin P; Huitrón-Résendiz S; Spier AD; Fabre V; Morte B; Criado JR; Sutcliffe JG; Henriksen SJ; de Lecea L
    J Neurosci; 2000 Oct; 20(20):7760-5. PubMed ID: 11027239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep transitions in hypocretin-deficient narcolepsy.
    Sorensen GL; Knudsen S; Jennum P
    Sleep; 2013 Aug; 36(8):1173-7. PubMed ID: 23904677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of pontine neurons during sleep and cataplexy in hypocretin knock-out mice.
    Thankachan S; Kaur S; Shiromani PJ
    J Neurosci; 2009 Feb; 29(5):1580-5. PubMed ID: 19193905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The spectrum of REM sleep-related episodes in children with type 1 narcolepsy.
    Antelmi E; Pizza F; Vandi S; Neccia G; Ferri R; Bruni O; Filardi M; Cantalupo G; Liguori R; Plazzi G
    Brain; 2017 Jun; 140(6):1669-1679. PubMed ID: 28472332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. To eat or to sleep? Orexin in the regulation of feeding and wakefulness.
    Willie JT; Chemelli RM; Sinton CM; Yanagisawa M
    Annu Rev Neurosci; 2001; 24():429-58. PubMed ID: 11283317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of sleep/wake disruption and cataplexy as hypocretin/orexin neurons degenerate in male vs. female Orexin/tTA; TetO-DTA Mice.
    Sun Y; Tisdale R; Park S; Ma SC; Heu J; Haire M; Allocca G; Yamanaka A; Morairty SR; Kilduff TS
    Sleep; 2022 Dec; 45(12):. PubMed ID: 35182424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of orexin neuron activity in sleep/wakefulness regulation.
    Hung C; Yamanaka A
    Peptides; 2023 Jul; 165():171007. PubMed ID: 37030519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle.
    Lee MG; Hassani OK; Jones BE
    J Neurosci; 2005 Jul; 25(28):6716-20. PubMed ID: 16014733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder.
    Luppi PH; Clément O; Sapin E; Gervasoni D; Peyron C; Léger L; Salvert D; Fort P
    Sleep Med Rev; 2011 Jun; 15(3):153-63. PubMed ID: 21115377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypocretin and its emerging role as a target for treatment of sleep disorders.
    Cao M; Guilleminault C
    Curr Neurol Neurosci Rep; 2011 Apr; 11(2):227-34. PubMed ID: 21170610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.
    Gerashchenko D; Blanco-Centurion C; Greco MA; Shiromani PJ
    Neuroscience; 2003; 116(1):223-35. PubMed ID: 12535955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice.
    Kaur S; Thankachan S; Begum S; Liu M; Blanco-Centurion C; Shiromani PJ
    PLoS One; 2009 Jul; 4(7):e6346. PubMed ID: 19623260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the hypocretinergic system in the integration of networks that dictate the states of arousal.
    Winsky-Sommerer R; Boutrel B; De Lecea L
    Drug News Perspect; 2003 Oct; 16(8):504-12. PubMed ID: 14668948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat.
    Xi MC; Morales FR; Chase MH
    Brain Res; 2001 May; 901(1-2):259-64. PubMed ID: 11368975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypocretin (orexin) immunoreactivity in the feline midbrain: Relevance for the generation of wakefulness.
    Costa A; Monti J; Torterolo P
    J Chem Neuroanat; 2020 Apr; 105():101769. PubMed ID: 32145304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S; Gammeltoft S; Jennum PJ
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.